Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
IMDX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $113.23M
- EPS (TTM)
- -$1.55
- Dividend yield
- None
- 52-week range
- 2.42 – 8.51
- Day range
- 3.26 – 3.67
- Volume / Avg
- 153.87K / 234.39K
- Beta
- —
- Shares outstanding
- 32.72M
52-week range
IMDX stock today
On Oct 7, IMDX ended the session at $3.46, adding $0.08 (2.37%), versus the S&P 500's 0.22% decline. At this level, IMDX sits near the bottom of its 52-week range of $2.42 to $8.51: 59.3% below the high, set on Nov 12, 2025 and 43.0% above the low. IMDX is down 53.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 6.0%.
Insight Molecular Diagnostics has posted a net loss over the last twelve months (EPS of -$1.55), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Insight Molecular Diagnostics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ICCCImmuCell Corporation | 9.69 | -2.81% | $88.01M | vs IMDX |
| NNNNAnbio Biotechnology Class A | 4.90 | 0.00% | $215.07M | vs IMDX |
| BMRABiomerica Inc. | 1.91 | -10.75% | $8.78M | vs IMDX |
| VNRXVolitionRX Limited | 0.226 | -6.96% | $6.79M | vs IMDX |
| CDIOCardio Diagnostics Holdings Inc. | 1.96 | -2.00% | $5.80M | vs IMDX |
| TRIBTrinity Biotech plc ADR | 6.75 | -5.59% | $5.49M | vs IMDX |
| QCLSQ/C Technologies Inc. | 0.632 | -8.42% | $5.18M | vs IMDX |
| VRAXVirax Biolabs Group Limited | 2.11 | +3.94% | $2.84M | vs IMDX |
Indexes, lists and sector
Insight Molecular Diagnostics stock FAQ
What is Insight Molecular Diagnostics's stock price today?
IMDX last traded at $3.46 as of Oct 7, 4:00 PM EDT, up 2.37% on the day. Prices are delayed at least 15 minutes.
Does Insight Molecular Diagnostics pay a dividend?
No. Insight Molecular Diagnostics does not currently pay a regular cash dividend.
Has IMDX ever split its stock?
Yes. The most recent IMDX stock split was a 1-for-20 split on Jul 25, 2023.
What is the IMDX 52-week high?
The 52-week high for IMDX is $8.51 and the 52-week low is $2.42. The stock is currently 59.3% below its high.